Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A

J. G. van der Bom; S. C. Gouw; F. R. Rosendaal

doi:https://doi.org/10.1111/hae.12342

Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A

J. G. van der Bom, S. C. Gouw, F. R. Rosendaal

Research output: Contribution to journal › Comment/Letter to the editor › Academic

15 Citations (Scopus)

Original language	English
Pages (from-to)	e171-e174
Journal	Haemophilia
Volume	20
Issue number	2
DOIs	https://doi.org/10.1111/hae.12342
Publication status	Published - 2014

Access to Document

https://doi.org/10.1111/hae.12342

Cite this

@article{5701d84cc6a14e468c7dda8a587b9148,

title = "Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A",

author = "{van der Bom}, {J. G.} and Gouw, {S. C.} and Rosendaal, {F. R.}",

year = "2014",

doi = "https://doi.org/10.1111/hae.12342",

language = "English",

volume = "20",

pages = "e171--e174",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A

AU - van der Bom, J. G.

AU - Gouw, S. C.

AU - Rosendaal, F. R.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1111/hae.12342

DO - https://doi.org/10.1111/hae.12342

M3 - Comment/Letter to the editor

C2 - 24372628

SN - 1351-8216

VL - 20

SP - e171-e174

JO - Haemophilia

JF - Haemophilia

IS - 2

ER -